- Home
- Products
- Customized ADCs
- ERBB2
- Anti-ERBB2 (Trastuzumab)-NGM-doxorubicin ADC
Anti-ERBB2 (Trastuzumab)-NGM-doxorubicin ADC (CAT#: ADC-W-412)
This ADC product is comprised of an anti-ERBB2 monoclonal antibody conjugated via a NGM linker to adoxorubicin. The doxorubicin is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, doxorubicin binds to DNA, causes DNA damage.
- ADC Target
- ADC Antibody
- ADC Linker
- ADC payload drug
- Name
- ERBB2
- Alternative Names
- ERBB2; erb-b2 receptor tyrosine kinase 2; NEU; NGL; HER2; TKR1; CD340; HER-2; MLN 19; HER-2/neu; receptor tyrosine-protein kinase erbB-2; herstatin; p185erbB2; proto-oncogene Neu; c-erb B2/neu protein; proto-oncogene c-ErbB-2; metastatic lymph node gene 1
- Target Entrez Gene ID
- 2064
- Target UniProt ID
- P04626
- Overview
- This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Allelic variations at amino acid positions 654 and 655 of isoform a (positions 624 and 625 of isoform b) have been reported, with the most common allele, Ile654/Ile655, shown here. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized.
- Overview
- Humanized Anti-ERBB2 Antibody, Trastuzumab
- Generic name
- Trastuzumab
- Species Reactivity
- Human
- Name
- NGM
- Name
- doxorubicin
- Description
- Doxorubicin is the generic name for the trade name drug, Adriamycin®, as well as, Rubex®, which is a type of anti-cancer chemotherapy drug called an anthracycline. Doxorubicin works by blocking an enzyme called TopoisomeraseⅡthat cancer cells need to divide and grow.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-AOC3 (Vepalimomab)-MC-MMAF ADC (CAT#: ADC-W-676)
- Anti-CD40LG (Dapirolizumab pegol)-SPDB-DM4 ADC (CAT#: ADC-W-2445)
- Anti-NOTCH2 (Tarextumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (CAT#: ADC-W-2221)
- Anti-SOST (Blosozumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (CAT#: ADC-W-1771)
- Anti-ERBB2 (Trastuzumab) Fab -Porphyrin ADC (CAT#: ADC-W-420)
- Anti-CD22 (10F4v3)-SPP-DM1 ADC (CAT#: ADC-W-625)
- Anti-CA9-VC-MMAE ADC (CAT#: ADC-W-475)
- Anti-CD70-DM1 ADC (CAT#: ADC-W-567)
- Anti-ITGAV (Intetumumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-1493)
- Anti-ERBB3 (Duligotumab)-SMCC-DM1 ADC (CAT#: ADC-W-2240)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-412. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
Same Payload
CAT# | Product Name | Linker | Payload |
ADC-W-1115 | Anti-ERBB2 (Pertuzumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
ADC-W-1112 | Anti-ERBB2 (Pertuzumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
ADC-W-582 | Anti-ERBB2-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
ADC-W-116 | Anti-ERBB2 (Trastuzumab)-Gly5-modified DM1 ADC | C-terminal GS (glycine-serine) linker | Gly5-modified DM1 (Gly5-modified N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
ADC-W-1110 | Anti-ERBB2 (Margetuximab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
CAT# | Product Name | Linker | Payload |
ADC-W-502 | Anti-EGFR-SMCC-Dox ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | Doxorubicin |
ADC-W-378 | Anti-CD74-hindered disulfide-Doxorubicin ADC | hindered disulfide | doxorubicin |
ADC-W-571 | Anti-ERBB2 (Trastuzumab)-DOX ADC | thiomaleamicacids-p-aminobenzyloxycarbonyl | doxorubicin |
ADC-W-600 | Anti-EGFR-doxorubicin ADC | polyethylene glycol linker | doxorubicin |
ADC-W-581 | Anti-EpCAM (MOC31)-hydrazone-Doxorubicin ADC | acid-cleavable hydrazone linker | doxorubicin |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.